Peter Rowe

Source: Dr. Peter Rowe's website

Peter C. Rowe, MD, is the director of the John Hopkins Children's Center Chronic Fatigue Clinic in Baltimore, Maryland, USA, and a professor of Pediatrics at John Hopkins University School of Medicine, Baltimore, Maryland, USA.

As a leader in the field of pediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Dr Rowe is invited as a frequent guest at ME/CFS conferences and served as one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report, and serves on the Solve ME/CFS Initiative Research Advisory Council.

He lists his fields of expertise as: Adolescent Medicine, Chronic Fatigue Syndrome, Fibromyalgia, General Pediatrics, Orthostatic Intolerance, Pediatrics and his research interests as: Chronic Fatigue Syndrome; Fibromyalgia; Elhers-Danlos Syndrome; Orthostatic intolerance syndromes; Gulf War Illness; and Pelvic congestion syndrome.

Awards

• 2014, Research Award, awarded by International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Clinic Location

Johns Hopkins Pediatrics

Appointment Phone: 410-955-9229

200 N. Wolfe Street

Rubenstein Child Health Building

Baltimore, MD 21287

For information on requesting an appointment.

2017 Pediatric Primer

Dr. Rowe was one of the authors of the 2017 Pediatric Primer published in Frontiers in Pediatrics.

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer by Peter Rowe, Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Malcolm S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings and Katherine S. Rowe (Full Text)

ME/CFS Common Data Element (CDE) Project

Chair of the Autonomic Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control & Prevention.

Notable studies

• 1995, The relationship between neurally mediated hypotension and the chronic fatigue syndrome (Abstract)
• 1997, Comparison of heart rate variability in patients with chronic fatigue syndrome and controls (Abstract)
• 1998, Neurally mediated hypotension and chronic fatigue syndrome (Abstract)
• 1999, Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome (Abstract)
• 2003, Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome (Abstract)
• 2007, Successful use of a primary care practice-specialty collaboration in the care of an adolescent with chronic fatigue syndrome (Abstract)
• 2013, Neuromuscular strain as a contributor to cognitive and other symptoms in chronic fatigue syndrome: hypothesis and conceptual model (Full Text)
• 2013, What is brain fog? An evaluation of the symptom in postural tachycardia syndrome (Full Text)
• 2014, Impaired range of motion of limbs and spine in chronic fatigue syndrome (Abstract)
• 2014, Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial (Full Text)
• 2016, Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome (Full Text)
• 2016, Cow's milk protein intolerance in adolescents and young adults with chronic fatigue syndrome (Abstract)
• 2018, Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome (Full text)
• 2018, Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis (Full Text)
• 2018, Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome (Full text)

Medscape Continuing Medicine Education

• 2013, A Case-Based Approach to Chronic Fatigue Syndrome was a Medscape Continuing Medicine Education program co-authored by Dr Lisa Corbin, Dr Anthony Komaroff, Dr Benjamin Natelson, and Dr Peter Rowe.

Webinars

• Jul 16, 2015, "Inducing Post-Exertional Malaise in ME/CFS: A Look at the Research Evidence"
• Mar 17, 2017, " A Clinical Approach to ME/CFS in Adolescent and Young Adults: A Practical Primer"

Part 1 - Written questions and answers to Dr. Rowe's webinar

Part 2 - Written questions and answers to Dr. Rowe's webinar

Part 3 - Written questions and answers to Dr. Rowe's webinar

Part 4 - Written questions and answers to Dr. Rowe's webinar

• Oct 23, 2014, "Neuromuscular Strain in ME/CFS"
• September 2010, "Mangaging Orthostatic Intolerance"

Talks and Interviews

• 2000 Documentary, I Remember Me, directed by Kim A. Snyder
• 2016, 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, Diagnosing and Treating Orthostatic Intolerance

See also

• I Remember Me
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
• International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
• Solve ME/CFS Initiative

chronic fatigue (CF) - Persistent and abnormal fatigue is a symptom, not an illness. It may be caused by depression, multiple sclerosis, fibromyalgia, chronic fatigue syndrome or many other illnesses. The term "chronic fatigue" should never be confused with the disease chronic fatigue syndrome.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

heart rate (HR) - the number of times the heart beats within a certain time period, usually a minute

cerebral 1. of or relating to the brain or the intellect 2. of, relating to, affecting, or being the cerebrum.

muscle strain An injury involving a stretched or torn muscle or tendon (tendons are fibrous cords of tissue that connect muscle to bone).

cognition Thought processes, including attention, reasoning, and memory.

muscle strain An injury involving a stretched or torn muscle or tendon (tendons are fibrous cords of tissue that connect muscle to bone).

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

tachycardia An unusually rapid heart beat. Can be caused by exercise or illness. A symptom of postural orthostatic tachycardia syndrome (POTS). (Learn more: www.heart.org)